Myeloproliferative neoplasms: open trials in Switzerland

3 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT07357727
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Basel · Bern · Geneva · Genolier
Registry updated 2026-11-06
NCT07623200
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Trial Treatment · Phase 3 · Incyte Corporation
University Hospital Bern / Inselspital, Bern · HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen · Center of Oncology, Hematology and Transfusionmedicine, Tellstrasse · Universitätsspital Zürich, Zurich
Registry updated 2026-11-05
NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Trial Treatment · Phase 2 · Cogent Biosciences, Inc.
Universitätsspital Basel, Basel
Registry updated 2026-09-15

This page is not medical advice. Talk to your doctor before contacting a trial.

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)